Inventor

ZURAWSKI GERARD

US52 patents

⚠️ This page may combine multiple inventors who share the name “ZURAWSKI GERARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZURAWSKI GERARD

BAYLOR RES INSTITUTE

Vaccines against HPV and HPV-related diseases

Vaccines against HPV and HPV-related diseases

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

Vaccines against HPV and HPV-related diseases

Nucleic acids encoding anti-CD40 antibodies

Anti-CD40 antibodies

Method of making an anti-CD40 antibody

Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides

Fusion proteins comprising an anti-CD40 antibody and cancer antigens

Fusion proteins comprising an anti-CD40 antibody and cancer antigens

Compositions and methods to immunize against hepatitis C virus

Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis

Vaccines against HPV and HPV-related diseases

Methods and compositions for treating autoimmune and inflammatory conditions

Methods and compositions for treating autoimmune and inflammatory conditions

SCHERING CORP

IL-17-like cytokine binding compounds and antibodies

Muteins of mammalian cytokine interleukin-13

Nucleic acids encoding mammalian proteinases; related reagents

Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor

Method of refolding human IL-13

T cell activation markers

Truncated human interleukin-a alpha

IL-17-like cytokine binding compounds and antibodies

Purified mammalian cytokines; related reagents and methods

Mammalian proteases; related reagents

Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptor

T cell activation markers

Nucleic acids encoding murine IL-174

Purified mammalian cytokine IL-174 polypeptides

ZURAWSKI GERARD

Anti-CD40 targeted fusion proteins

Fusion protein with HIV antigen

Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

Fusion proteins comprising antibody and HPV E6 and E7 antigens

Antigen presenting cell targeted anti-viral vaccines

Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

BAYLOR RES INST

Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

Multivariable antigens complexed with targeting humanized monoclonal antibody

Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells

Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)

Anti-CD40 antibodies

Vaccines directed to langerhans cells

BANCHEREAU JACQUES F

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

Anti-CD40 antibodies

Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef

Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)

INST NAT SANTE RECH MED

Methods and compositions for treating and preventing HIV

Methods and compositions for treating and preventing HIV

Methods and compositions for treating and preventing HIV

OH SANGKON

Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2)